Top mergers and acquisitions in Switzerland in November 2026
Every verified merger and acquisition involving Switzerland in this period, ranked by disclosed value. Updated every morning.
We tracked 2 deals involving Switzerland in November 2026, 2 of them with a disclosed value, worth $2.4bn in total. The largest was Samsung Biologics's $1.8bn deal for PolyPeptide Group AG, ahead of Ahlsell AB (publ) and Meier Tobler Group AG at $600m.
Top mergers and acquisitions in Switzerland in November 2026
- 12 NovSamsung Biologics → PolyPeptide Group AGSamsung secures 98% of PolyPeptide as offer awaits final clearancesHealthcare / Pharma CDMOIn review$1.8bn
- 24 NovAhlsell AB (publ) → Meier Tobler Group AGAhlsell bids CHF 492m for Swiss building-technology group Meier ToblerIndustrials / Building technology wholesaleAgreed$600m